332 related articles for article (PubMed ID: 25104135)
1. Utilising polyphenols for the clinical management of Candida albicans biofilms.
Shahzad M; Sherry L; Rajendran R; Edwards CA; Combet E; Ramage G
Int J Antimicrob Agents; 2014 Sep; 44(3):269-73. PubMed ID: 25104135
[TBL] [Abstract][Full Text] [Related]
2. Selected dietary (poly)phenols inhibit periodontal pathogen growth and biofilm formation.
Shahzad M; Millhouse E; Culshaw S; Edwards CA; Ramage G; Combet E
Food Funct; 2015 Mar; 6(3):719-29. PubMed ID: 25585200
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of micafungin against biofilms of Candida albicans, Candida glabrata, and Candida parapsilosis at different stages of maturation.
Prażyńska M; Bogiel T; Gospodarek-Komkowska E
Folia Microbiol (Praha); 2018 Mar; 63(2):209-216. PubMed ID: 28983822
[TBL] [Abstract][Full Text] [Related]
4. In vitro antifungal activity of baicalin against Candida albicans biofilms via apoptotic induction.
Wang T; Shi G; Shao J; Wu D; Yan Y; Zhang M; Cui Y; Wang C
Microb Pathog; 2015 Oct; 87():21-9. PubMed ID: 26169236
[TBL] [Abstract][Full Text] [Related]
5. Synergistic effect of doxycycline and fluconazole against Candida albicans biofilms and the impact of calcium channel blockers.
Gao Y; Zhang C; Lu C; Liu P; Li Y; Li H; Sun S
FEMS Yeast Res; 2013 Aug; 13(5):453-62. PubMed ID: 23577622
[TBL] [Abstract][Full Text] [Related]
6. Antifungal activity of amphotericin B and voriconazole against the biofilms and biofilm-dispersed cells of Candida albicans employing a newly developed in vitro pharmacokinetic model.
El-Azizi M; Farag N; Khardori N
Ann Clin Microbiol Antimicrob; 2015 Apr; 14():21. PubMed ID: 25885806
[TBL] [Abstract][Full Text] [Related]
7. Chemical composition and antifungal activity of Satureja hortensis L. essentiall oil against planktonic and biofilm growth of Candida albicans isolates from buccal lesions of HIV(+) individuals.
Sharifzadeh A; Khosravi AR; Ahmadian S
Microb Pathog; 2016 Jul; 96():1-9. PubMed ID: 27126187
[TBL] [Abstract][Full Text] [Related]
8. Effect of ferrocene-substituted porphyrin RL-91 on Candida albicans biofilm formation.
Lippert R; Vojnovic S; Mitrovic A; Jux N; Ivanović-Burmazović I; Vasiljevic B; Stankovic N
Bioorg Med Chem Lett; 2014 Aug; 24(15):3506-11. PubMed ID: 24929472
[TBL] [Abstract][Full Text] [Related]
9. Antifungal susceptibility of Candida albicans in biofilms.
Tobudic S; Kratzer C; Lassnigg A; Presterl E
Mycoses; 2012 May; 55(3):199-204. PubMed ID: 21793943
[TBL] [Abstract][Full Text] [Related]
10. Thymol inhibits Candida albicans biofilm formation and mature biofilm.
Braga PC; Culici M; Alfieri M; Dal Sasso M
Int J Antimicrob Agents; 2008 May; 31(5):472-7. PubMed ID: 18329858
[TBL] [Abstract][Full Text] [Related]
11. Biofilm inhibition by Cymbopogon citratus and Syzygium aromaticum essential oils in the strains of Candida albicans.
Khan MS; Ahmad I
J Ethnopharmacol; 2012 Mar; 140(2):416-23. PubMed ID: 22326355
[TBL] [Abstract][Full Text] [Related]
12. Terpenoids of plant origin inhibit morphogenesis, adhesion, and biofilm formation by Candida albicans.
Raut JS; Shinde RB; Chauhan NM; Karuppayil SM
Biofouling; 2013; 29(1):87-96. PubMed ID: 23216018
[TBL] [Abstract][Full Text] [Related]
13. Antifungal activity of cathelicidin peptides against planktonic and biofilm cultures of Candida species isolated from vaginal infections.
Scarsini M; Tomasinsig L; Arzese A; D'Este F; Oro D; Skerlavaj B
Peptides; 2015 Sep; 71():211-21. PubMed ID: 26238597
[TBL] [Abstract][Full Text] [Related]
14. Cyclosporine A decreases the fluconazole minimum inhibitory concentration of Candida albicans clinical isolates but not biofilm formation and cell growth.
Wibawa T; Nurrokhman ; Baly I; Daeli PR; Kartasasmita G; Wijayanti N
Trop Biomed; 2015 Mar; 32(1):176-82. PubMed ID: 25801268
[TBL] [Abstract][Full Text] [Related]
15. The inhibitory activity of linalool against the filamentous growth and biofilm formation in Candida albicans.
Hsu CC; Lai WL; Chuang KC; Lee MH; Tsai YC
Med Mycol; 2013 Jul; 51(5):473-82. PubMed ID: 23210679
[TBL] [Abstract][Full Text] [Related]
16. Effect of alkylphospholipids on Candida albicans biofilm formation and maturation.
Vila TV; Ishida K; de Souza W; Prousis K; Calogeropoulou T; Rozental S
J Antimicrob Chemother; 2013 Jan; 68(1):113-25. PubMed ID: 22995097
[TBL] [Abstract][Full Text] [Related]
17. Development of
Lee HS; Kim Y
J Microbiol Biotechnol; 2018 Mar; 28(3):482-490. PubMed ID: 29316739
[No Abstract] [Full Text] [Related]
18. The effect of silver nanoparticles and nystatin on mixed biofilms of Candida glabrata and Candida albicans on acrylic.
Silva S; Pires P; Monteiro DR; Negri M; Gorup LF; Camargo ER; Barbosa DB; Oliveira R; Williams DW; Henriques M; Azeredo J
Med Mycol; 2013 Feb; 51(2):178-84. PubMed ID: 22803822
[TBL] [Abstract][Full Text] [Related]
19. Antifungal activity of a prenylated flavonoid from Dalea elegans against Candida albicans biofilms.
Peralta MA; da Silva MA; Ortega MG; Cabrera JL; Paraje MG
Phytomedicine; 2015 Oct; 22(11):975-80. PubMed ID: 26407939
[TBL] [Abstract][Full Text] [Related]
20. Synergistic activity of lysozyme and antifungal agents against Candida albicans biofilms on denture acrylic surfaces.
Samaranayake YH; Cheung BP; Parahitiyawa N; Seneviratne CJ; Yau JY; Yeung KW; Samaranayake LP
Arch Oral Biol; 2009 Feb; 54(2):115-26. PubMed ID: 19038377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
